Search

Your search keyword '"Harris, Shannon L."' showing total 191 results

Search Constraints

Start Over You searched for: Author "Harris, Shannon L." Remove constraint Author: "Harris, Shannon L."
191 results on '"Harris, Shannon L."'

Search Results

1. Instructional Approaches: Anatomy Education of Physical Therapists

6. Inclusive Aquatics Environments Start With You

13. A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

15. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

21. Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months

25. Synthesis and characterization of polyethylene glycol polyacrylamide coplymer (PEGA) resins containing carbohydrate ligands: evaluation as supports for affinity chromatography

26. Transferred nuclear overhauser enhancement experiments show that the monoclonal antibody Strep 9 selects a local minimum conformation of a Streptococcus group A trisaccharide-hapten

28. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

31. Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine

32. A Phase 2 Study of the Immunogenicity, Safety, and Tolerability of MenB-FHbp, a Bivalent Meningococcal B Vaccine, in Healthy Toddlers

34. Meningococcal serogroup B vaccines: Estimating breadth of coverage

36. A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents

37. Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

38. Immunogenicity of MenB-FHbp (Bivalent rLP2086), a Meningococcal Serogroup B Vaccine, in US Adolescents: Results From a Phase 3 Trial

39. Minority Language Learners: A look at culturally relevant resources available at elementary schools in North Carolina

40. Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents

41. Immunogenicity and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tdap and MCV4 in US Adolescents

42. Nutrient dynamics in a highly managed reservoir system: considering anadromous sockeye salmon ( Oncorhynchus nerka ) and nutrient restoration.

44. Nutrient and phytoplankton dynamics off the west coast of Vancouver Island during the 1997/98 ENSO event

47. A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

50. Safety and Immunogenicity of a Meningococcal B Bivalent rLP2086 Vaccine in Healthy Toddlers Aged 18–36 Months

Catalog

Books, media, physical & digital resources